---
title: "ANKE BIO: Net profit in the first half of 2025 is 367 million yuan, a year-on-year decrease of 11.92%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253971285.md"
description: "ANKE BIO announced that its operating revenue in the first half of 2025 was 1.292 billion yuan, a year-on-year decrease of 0.51%. Net profit was 367 million yuan, a year-on-year decrease of 11.92%"
datetime: "2025-08-21T10:55:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253971285.md)
  - [en](https://longbridge.com/en/news/253971285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253971285.md)
---

# ANKE BIO: Net profit in the first half of 2025 is 367 million yuan, a year-on-year decrease of 11.92%

ANKE BIO announced that its operating revenue in the first half of 2025 was 1.292 billion yuan, a year-on-year decrease of 0.51%. The net profit was 367 million yuan, a year-on-year decrease of 11.92%

### Related Stocks

- [300009.CN](https://longbridge.com/en/quote/300009.CN.md)

## Related News & Research

- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [15:55 ETInception Fertility Launches MySpermBank, Expanding Access to Donor Sperm Services Nationwide](https://longbridge.com/en/news/287265370.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [LG CNS Expands North American AX Business, Supporting Smart Factory Transformation for SMEs](https://longbridge.com/en/news/286971453.md)